Phase 1 × Completed × Central Nervous System Neoplasms × Clear all EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors
Phase 1 Completed
11 enrolled
EPO906 Plus Radiation Therapy for the Treatment of Cancer Patients
Phase 1 Completed
39 enrolled
A Trial Using Velcade Plus Chemoradiation for Central Nervous System, Head and Neck, and Cervical Cancer Patients
Phase 1 Completed
54 enrolled
Evaluation of LY2606368 Therapy in Combination With Cyclophosphamide or Gemcitabine for Children and Adolescents With Refractory or Recurrent Group 3/Group 4 or SHH Medulloblastoma Brain Tumors
Phase 1 Completed
21 enrolled
Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas
Phase 1 Completed
59 enrolled 20 charts
Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
Phase 1 Completed
33 enrolled 15 charts
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
Phase 1 Completed
68 enrolled
COZMOS
Phase 1 Completed
31 enrolled
Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors
Phase 1 Completed
Cabozantinib S-Malate in Treating Younger Patients With Recurrent or Refractory Solid Tumors
Phase 1 Completed
41 enrolled 20 charts
Hyperpolarized Carbon C 13 Pyruvate Magnetic Resonance Spectroscopic Imaging in Detecting Lactate and Bicarbonate in Participants With Central Nervous System Tumors
Phase 1 Completed
9 enrolled 6 charts
Prexasertib in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
Phase 1 Completed
30 enrolled 16 charts
Stereotactic Radiosurgery in Treating Patients With Brain Tumors
Phase 1 Completed
Entinostat in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors
Phase 1 Completed
21 enrolled 15 charts
Durvalumab in Pediatric and Adolescent Patients
Phase 1 Completed
15 enrolled
Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme
Phase 1 Completed
32 enrolled
Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study
Phase 1 Completed
230 enrolled
Study of Irinotecan and Bevacizumab With Temozolomide in Refractory/Relapsed Central Nervous System (CNS) Tumors
Phase 1 Completed
26 enrolled 16 charts
Study of BLZ-100 in Pediatric Subjects With CNS Tumors
Phase 1 Completed
29 enrolled
Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas
Phase 1 Completed
27 enrolled
Pomalidomide in Treating Younger Patients With Recurrent, Progressive, or Refractory Central Nervous System Tumors
Phase 1 Completed
29 enrolled
A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors
Phase 1 Completed
29 enrolled 12 charts
Vaccine Therapy in Treating Patients With Malignant Glioma
Phase 1 Completed
28 enrolled
Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma
Phase 1 Completed
19 enrolled
Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors
Phase 1 Completed
21 enrolled
Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS Tumours
Phase 1 Completed
14 enrolled
Phase I Study of MLN8237 and Pazopanib in Patients With Solid Tumors
Phase 1 Completed
28 enrolled
Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma
Phase 1 Completed
28 enrolled
Gene Therapy in Treating Patients With Primary Brain Tumors
Phase 1 Completed
Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma
Phase 1 Completed
3 enrolled
O(6)-Benzylguanine in Treating Patients With Malignant Glioma
Phase 1 Completed
Gene Therapy in Treating Patients With Recurrent Malignant Gliomas
Phase 1 Completed
Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme
Phase 1 Completed
6 enrolled
Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma
Phase 1 Completed
ABT-888, Radiation Therapy, and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 1 Completed
24 enrolled
Temozolomide in Treating Patients With Primary Brain Tumors or Metastatic Brain Tumors
Phase 1 Completed
12 enrolled
A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors
Phase 1 Completed
12 enrolled
Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma
Phase 1 Completed
34 enrolled
Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma
Phase 1 Completed
3 enrolled
Assessing the Suitability of an Imaging Probe for Use in Clinical Cell and Gene Therapy Trials in Cancer and Rheumatoid Arthritis
Phase 1 Completed
10 enrolled
Vaccine Therapy in Treating Patients Undergoing Surgery for Recurrent Glioblastoma Multiforme
Phase 1 Completed
50 enrolled
Trebananib in Treating Younger Patients With Relapsed or Refractory Solid Tumors, Including Central Nervous System Tumors
Phase 1 Completed
37 enrolled
Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
Phase 1 Completed
27 enrolled
Iodine I 131 Monoclonal Antibody TNT-1/B in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme
Phase 1 Completed
22 enrolled
Study of Peptide Vaccination With Tumor Associated Antigens Mixed With Montanide in Patients With CNS Tumors
Phase 1 Completed
15 enrolled
Adjunctive Donepezil Therapy and Genetic Risk Factors of Cognitive Dysfunction in Brain Tumor Survivors
Phase 1 Completed
25 enrolled
Spectroscopy With Surface Coils and Decoupling
Phase 1 Completed
582 enrolled
Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma
Phase 1 Completed
37 enrolled
A Trial of Everolimus and Bevacizumab in Children With Recurrent Solid Tumors
Phase 1 Completed
16 enrolled
Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
Phase 1 Completed
45 enrolled